Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06954779 · ClinicalTrials.gov registry record · Phase 3
Arginine Plaque Metabolism Pilot Clinical Study
A Phase 3 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
NCT06954779 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 20 participants.
The verdict
NCT06954779, a Phase 3 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
Study Summary
Proof of concept clinical study to measure plaque metabolism and the prebiotic efficacy of arginine-containing toothpaste.
Interventions
- DRUG Colgate Cavity Protection
- DRUG TOM's Superior Sensitivity Relief Toothpaste
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-07-24 |
| Est. Completion | 2024-09-20 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06954779
The ClinicalTrials.gov registry entry for NCT06954779 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Colgate Cavity Protection is the first listed.
NCT06954779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06954779 about?
NCT06954779 is a clinical study titled "Arginine Plaque Metabolism Pilot Clinical Study". Proof of concept clinical study to measure plaque metabolism and the prebiotic efficacy of arginine-containing toothpaste.
What is the current status of trial NCT06954779?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2024-07-24. Estimated completion is 2024-09-20.
What interventions are being tested in trial NCT06954779?
The interventions under investigation include: Colgate Cavity Protection (DRUG), TOM's Superior Sensitivity Relief Toothpaste (DRUG).
Who is sponsoring clinical trial NCT06954779?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.